Patent · US Active

Compounds as cannabinoid receptor ligands

US8492371B2 · kind B2 · utility

9Cited by

10References

17Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

William A. Carroll · Evanston, US
Michael J. Dart · Highland Park, US
Jennifer M. Frost · Grayslake, US
Steven P. Latshaw · Round Lake, US
Tongmei Li · Lake Bluff, US
Bo Liu · Beijing, CN
Sridhar Peddi · Grayslake, US
Xueqing Wang · Evanston, US
Teodozyj Kolasa · Lake Villa, US
Derek W. Nelson · Troy, US
Arturo Perez-Medrano · Grayslake, US

Key dates

Filing date	Mar 26, 2010
Grant date	Jul 23, 2013
Priority date	—
Expiry date	Jul 6, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compounds of formula (I)wherein Ring A and R1 are as defined in the specification. Pharmaceutical compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and pharmaceutical compositions are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.